Global Microscopic Polyangiitis (MPA) Treatment Industry Research Report 2020, Forecast to 2025

September 2020 | 105 pages | ID: GA3CD10C5FC6EN
WKinformation

Abstracts

The report requires updating with new data and is sent in 48 hours after order is placed.

The Microscopic Polyangiitis (MPA) Treatment market was valued at US$ xx in 2019, prior to COVID-19. Whereas post-COVID-19 scenario, the market for Microscopic Polyangiitis (MPA) Treatment is projected to grow from US$ xx million in 2020, and is projected to reach xx by 2025, at a CAGR of xx% during the forecast period. Projected and forecast revenue values are in constant U.S. dollars, unadjusted for inflation. Product values are estimated based on manufacturers' revenue.

The report offers detailed coverage of Microscopic Polyangiitis (MPA) Treatment industry and main market trends. The market research includes historical and forecast market data, demand, application details, price trends, and company shares of the leading Microscopic Polyangiitis (MPA) Treatment by geography. The report splits the market size, by volume and value, on the basis of application type and geography.

In addition to this data, the report provides insight into drivers of market demand and strategies of suppliers. Key players are profiled, and their market shares in the global Microscopic Polyangiitis (MPA) Treatment market are discussed.

The market is segmented by types:

• Avacopan
• Immune Globulin
• Rituximab Biosimilar
• Others

It can be also divided by applications:

• Hospital
• Clinic
• Others

And this report covers the historical situation, present status and the future prospects of the global Microscopic Polyangiitis (MPA) Treatment market for 2015-2025. In this report, we analyze global market from 5 geographies: Asia-Pacific, Europe, North America, Middle East & Africa, South America.

Finally, the report provides detailed profile and data information analysis of leading company.

• Celltrion Inc
• Teijin Pharma Ltd
• ChemoCentryx Inc
• Sandoz International GmbH
• TTY Biopharm Company Ltd

Report Includes:

• xx data tables and xx additional tables
• An overview of global Microscopic Polyangiitis (MPA) Treatment market
• An detailed key players analysis across regions
• Analyses of global market trends, with historical data, estimates for 2020 and projections of compound annual growth rates (CAGRs) through 2025
• Insights into regulatory and environmental developments
• Information on the supply and demand scenario and evaluation of technological and investment opportunities in the Microscopic Polyangiitis (MPA) Treatment market
• Profiles of major players in the industry, including Celltrion Inc, Teijin Pharma Ltd, ChemoCentryx Inc, Sandoz International GmbH, TTY Biopharm Company Ltd.....

Research Objectives

• To study and analyze the global Microscopic Polyangiitis (MPA) Treatment consumption (value & volume) by key regions/countries, product type and application, history data from 2015 to 2019, and forecast to 2025.
• To understand the structure of Microscopic Polyangiitis (MPA) Treatment market by identifying its various subsegments.
• Focuses on the key global Microscopic Polyangiitis (MPA) Treatment manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, Porter's five forces analysis, SWOT analysis and development plans in next few years.
• To analyze the Microscopic Polyangiitis (MPA) Treatment with respect to individual growth trends, future prospects, and their contribution to the total market.
• To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
• To project the consumption of Microscopic Polyangiitis (MPA) Treatment submarkets, with respect to key regions (along with their respective key countries).
• To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
• To strategically profile the key players and comprehensively analyze their growth strategies.

Contents

Global Microscopic Polyangiitis (MPA) Treatment Market Report 2020, Forecast to 2025

1 SCOPE OF THE STUDY

1.1 Microscopic Polyangiitis (MPA) Treatment Introduction
1.2 Research Programs
1.3 Analysis of Macroeconomic Indicators
1.4 Years Considered
1.5 Methodology
1.6 Data Source
1.7 Research Objectives

2 MICROSCOPIC POLYANGIITIS (MPA) TREATMENT INDUSTRY OVERVIEW

2.1 Global Microscopic Polyangiitis (MPA) Treatment Market Size (Million USD) Comparison by Regions (2020-2025)
  2.1.1 Microscopic Polyangiitis (MPA) Treatment Global Import Market Analysis
  2.1.2 Microscopic Polyangiitis (MPA) Treatment Global Export Market Analysis
  2.1.3 Microscopic Polyangiitis (MPA) Treatment Global Main Region Market Analysis
2.2 Market Analysis by Type
  2.2.1 Avacopan
  2.2.2 Immune Globulin
  2.2.3 Rituximab Biosimilar
  2.2.4 Others
2.3 Market Analysis by Application
  2.3.1 Hospital
  2.3.2 Clinic
  2.3.3 Others
2.4 Global Microscopic Polyangiitis (MPA) Treatment Revenue, Sales and Market Share by Manufacturer
  2.4.1 Global Microscopic Polyangiitis (MPA) Treatment Sales and Market Share by Manufacturer (2018-2020)
  2.4.2 Global Microscopic Polyangiitis (MPA) Treatment Revenue and Market Share by Manufacturer (2018-2020)
  2.4.3 Global Microscopic Polyangiitis (MPA) Treatment Industry Concentration Ratio (CR5 and HHI)
  2.4.4 Top 5 Microscopic Polyangiitis (MPA) Treatment Manufacturer Market Share
  2.4.5 Top 10 Microscopic Polyangiitis (MPA) Treatment Manufacturer Market Share
  2.4.6 Date of Key Manufacturers Enter into Microscopic Polyangiitis (MPA) Treatment Market
  2.4.7 Key Manufacturers Microscopic Polyangiitis (MPA) Treatment Product Offered
  2.4.8 Mergers & Acquisitions Planning
2.5 Microscopic Polyangiitis (MPA) Treatment Historical Development Overview
2.6 Market Dynamics
  2.6.1 Market Opportunities
  2.6.2 Market Risk
  2.6.3 Market Driving Force
  2.6.4 Porter's Five Forces Analysis
2.7 Coronavirus Disease 2019 (Covid-19): Microscopic Polyangiitis (MPA) Treatment Industry Impact
  2.7.1 How the Covid-19 is Affecting the Microscopic Polyangiitis (MPA) Treatment Industry
  2.7.2 Microscopic Polyangiitis (MPA) Treatment Business Impact Assessment - Covid-19
  2.7.3 Market Trends and Microscopic Polyangiitis (MPA) Treatment Potential Opportunities in the COVID-19 Landscape
  2.7.4 Measures / Proposal against Covid-19

3 UPSTREAM AND DOWNSTREAM MARKET ANALYSIS

3.1 Upstream Analysis
  3.1.1 Macro Analysis of Upstream Markets
  3.1.2 Key Players in Upstream Markets
  3.1.3 Upstream Market Trend Analysis
  3.1.4 Microscopic Polyangiitis (MPA) Treatment Manufacturing Cost Analysis
3.2 Downstream Market Analysis
  3.2.1 Macro Analysis of Down Markets
  3.2.2 Key Players in Down Markets
  3.2.3 Downstream Market Trend Analysis
  3.2.4 Sales Channel, Distributors, Traders and Dealers

4 GLOBAL MICROSCOPIC POLYANGIITIS (MPA) TREATMENT MARKET SIZE CATEGORIZED BY REGIONS (2015-2020)

4.1 Global Microscopic Polyangiitis (MPA) Treatment Sales Market Share by Region
4.2 Global Microscopic Polyangiitis (MPA) Treatment Revenue Market Share by Region (2015-2019)
4.3 Global Microscopic Polyangiitis (MPA) Treatment Sales, Revenue, Price and Gross Margin (2015-2020)
4.4 North America Microscopic Polyangiitis (MPA) Treatment Market Size Detail
  4.4.1 North America Microscopic Polyangiitis (MPA) Treatment Sales Growth Rate (2015-2020)
  4.4.2 North America Microscopic Polyangiitis (MPA) Treatment Sales, Revenue, Price and Gross Margin (2015-2020)
4.5 Europe Microscopic Polyangiitis (MPA) Treatment Market Size Detail
  4.5.1 Europe Microscopic Polyangiitis (MPA) Treatment Sales Growth Rate (2015-2020)
  4.5.2 Europe Microscopic Polyangiitis (MPA) Treatment Sales, Revenue, Price and Gross Margin (2015-2020)
4.6 Japan Microscopic Polyangiitis (MPA) Treatment Market Size Detail
  4.6.1 Japan Microscopic Polyangiitis (MPA) Treatment Sales Growth Rate (2015-2020)
  4.6.2 Japan Microscopic Polyangiitis (MPA) Treatment Sales, Revenue, Price and Gross Margin (2015-2020)
4.7 China Microscopic Polyangiitis (MPA) Treatment Market Size Detail
  4.7.1 China Microscopic Polyangiitis (MPA) Treatment Sales Growth Rate (2015-2020)
  4.7.2 China Microscopic Polyangiitis (MPA) Treatment Sales, Revenue, Price and Gross Margin (2015-2020)

5 GLOBAL MICROSCOPIC POLYANGIITIS (MPA) TREATMENT MARKET SEGMENT BY TYPE

5.1 Global Microscopic Polyangiitis (MPA) Treatment Revenue, Sales and Market Share by Type (2015-2020)
  5.1.1 Global Microscopic Polyangiitis (MPA) Treatment Sales and Market Share by Type (2015-2020)
  5.1.2 Global Microscopic Polyangiitis (MPA) Treatment Revenue and Market Share by Type (2015-2020)
5.2 Avacopan Sales Growth Rate and Price
  5.2.1 Global Avacopan Sales Growth Rate (2015-2020)
  5.2.2 Global Avacopan Price (2015-2020)
5.3 Immune Globulin Sales Growth Rate and Price
  5.3.1 Global Immune Globulin Sales Growth Rate (2015-2020)
  5.3.2 Global Immune Globulin Price (2015-2020)
5.4 Rituximab Biosimilar Sales Growth Rate and Price
  5.4.1 Global Rituximab Biosimilar Sales Growth Rate (2015-2020)
  5.4.2 Global Rituximab Biosimilar Price (2015-2020)
5.5 Others Sales Growth Rate and Price
  5.5.1 Global Others Sales Growth Rate (2015-2020)
  5.5.2 Global Others Price (2015-2020)

6 GLOBAL MICROSCOPIC POLYANGIITIS (MPA) TREATMENT MARKET SEGMENT BY APPLICATION

6.1 Global Microscopic Polyangiitis (MPA) TreatmentSales Market Share by Application (2015-2020)
6.2 Hospital Sales Growth Rate (2015-2020)
6.3 Clinic Sales Growth Rate (2015-2020)
6.4 Others Sales Growth Rate (2015-2020)

7 GLOBAL MICROSCOPIC POLYANGIITIS (MPA) TREATMENT MARKET FORECAST

7.1 Global Microscopic Polyangiitis (MPA) Treatment Sales, Revenue Forecast
  7.1.1 Global Microscopic Polyangiitis (MPA) Treatment Sales Growth Rate Forecast (2020-2025)
  7.1.2 Global Microscopic Polyangiitis (MPA) Treatment Revenue and Growth Rate Forecast (2020-2025)
  7.1.3 Global Microscopic Polyangiitis (MPA) Treatment Price and Trend Forecast (2020-2025)
7.2 Global Microscopic Polyangiitis (MPA) Treatment Sales Forecast by Region (2020-2025)
  7.2.1 North America Microscopic Polyangiitis (MPA) Treatment Sales, Revenue Forecast (2020-2025)
  7.2.2 Europe Microscopic Polyangiitis (MPA) Treatment Sales, Revenue Forecast (2020-2025)
  7.2.3 Japan Microscopic Polyangiitis (MPA) Treatment Production, Revenue Forecast (2020-2025)
  7.2.4 China Microscopic Polyangiitis (MPA) Treatment Production, Revenue Forecast (2020-2025)

8 ANALYSIS OF MICROSCOPIC POLYANGIITIS (MPA) TREATMENT INDUSTRY KEY MANUFACTURERS

8.1 Celltrion Inc
  8.1.1 Company Details
  8.1.2 Product Information
  8.1.3 Celltrion Inc Microscopic Polyangiitis (MPA) Treatment Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
  8.1.4 Main Business Overview
  8.1.5 Celltrion Inc News
8.2 Teijin Pharma Ltd
  8.2.1 Company Details
  8.2.2 Product Information
  8.2.3 Teijin Pharma Ltd Microscopic Polyangiitis (MPA) Treatment Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
  8.2.4 Main Business Overview
  8.2.5 Teijin Pharma Ltd News
8.3 ChemoCentryx Inc
  8.3.1 Company Details
  8.3.2 Product Information
  8.3.3 ChemoCentryx Inc Microscopic Polyangiitis (MPA) Treatment Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
  8.3.4 Main Business Overview
  8.3.5 ChemoCentryx Inc News
8.4 Sandoz International GmbH
  8.4.1 Company Details
  8.4.2 Product Information
  8.4.3 Sandoz International GmbH Microscopic Polyangiitis (MPA) Treatment Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
  8.4.4 Main Business Overview
  8.4.5 Sandoz International GmbH News
8.5 TTY Biopharm Company Ltd
  8.5.1 Company Details
  8.5.2 Product Information
  8.5.3 TTY Biopharm Company Ltd Microscopic Polyangiitis (MPA) Treatment Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
  8.5.4 Main Business Overview
  8.5.5 TTY Biopharm Company Ltd News

9 RESEARCH FINDINGS AND CONCLUSION

10 APPENDIX

List Of Tables

LIST OF TABLES AND FIGURES

Figure Microscopic Polyangiitis (MPA) Treatment Picture
Figure Research Programs/Design for This Report
Figure Global Microscopic Polyangiitis (MPA) Treatment Market by Regions (2019)
Table Global Market Microscopic Polyangiitis (MPA) Treatment Comparison by Regions (M USD) 2019-2025
Table Global Microscopic Polyangiitis (MPA) Treatment Sales Growth (CAGR) (2019-2025) by Type
Figure Global Sales Market Share of Microscopic Polyangiitis (MPA) Treatment by Type in 2019
Figure Avacopan Picture
Figure Immune Globulin Picture
Figure Rituximab Biosimilar Picture
Figure Others Picture
Table Global Microscopic Polyangiitis (MPA) Treatment Sales by Application (2019-2025)
Figure Global Microscopic Polyangiitis (MPA) Treatment Sales Market Share by Application in 2019
Figure Hospital Picture
Figure Clinic Picture
Figure Others Picture
Table Global Microscopic Polyangiitis (MPA) Treatment Sales by Manufacturer (2018-2020)
Figure Global Microscopic Polyangiitis (MPA) Treatment Sales Market Share by Manufacturer in 2019
Table Global Microscopic Polyangiitis (MPA) Treatment Revenue by Manufacturer (2018-2020)
Figure Global Microscopic Polyangiitis (MPA) Treatment Revenue Market Share by Manufacturer in 2019
Table Global Microscopic Polyangiitis (MPA) Treatment Manufacturers Market Concentration Ratio (CR5 and HHI)
Figure Top 5 Microscopic Polyangiitis (MPA) Treatment Manufacturer (Revenue) Market Share in 2019
Figure Top 10 Microscopic Polyangiitis (MPA) Treatment Manufacturer (Revenue) Market Share in 2019
Table Date of Key Manufacturers Enter into Microscopic Polyangiitis (MPA) Treatment Market
Table Key Manufacturers Microscopic Polyangiitis (MPA) Treatment Product Type
Table Mergers & Acquisitions Planning
Table Market Opportunities in Next Few Years
Table Market Risks Analysis
Table Market Drivers
Table Key Players of Upstream Markets
Table Key Raw Materials
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Microscopic Polyangiitis (MPA) Treatment
Table Key Players of Upstream Markets
Figure Sales Channel
Table Global Microscopic Polyangiitis (MPA) Treatment Sales (K Units) by Region (2015-2020)
Table Global Microscopic Polyangiitis (MPA) Treatment Sales Market Share by Region (2015-2019)
Figure Global Microscopic Polyangiitis (MPA) Treatment Sales Market Share by Region (2015-2019)
Figure Global Microscopic Polyangiitis (MPA) Treatment Sales Market Share by Region in 2018
Table Global Microscopic Polyangiitis (MPA) Treatment Revenue (Million US$) by Region (2015-2020)
Table Global Microscopic Polyangiitis (MPA) Treatment Revenue Market Share by Region (2015-2020)
Figure Global Microscopic Polyangiitis (MPA) Treatment Revenue Market Share by Region (2015-2020)
Figure Global Microscopic Polyangiitis (MPA) Treatment Revenue Market Share by Region in 2019
Table Global Microscopic Polyangiitis (MPA) Treatment Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Figure North America Microscopic Polyangiitis (MPA) Treatment Sales (K Units) Growth Rate (2015-2020)
Table North America Microscopic Polyangiitis (MPA) Treatment Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Figure Europe Microscopic Polyangiitis (MPA) Treatment Sales (K Units) Growth Rate (2015-2020)
Table Europe Microscopic Polyangiitis (MPA) Treatment Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Figure Japan Microscopic Polyangiitis (MPA) Treatment Sales (K Units) Growth Rate (2015-2020)
Table Japan Microscopic Polyangiitis (MPA) Treatment Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Figure China Microscopic Polyangiitis (MPA) Treatment Sales (K Units) Growth Rate (2015-2020)
Table China Microscopic Polyangiitis (MPA) Treatment Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table Global Microscopic Polyangiitis (MPA) Treatment Sales by Type (2015-2020)
Table Global Microscopic Polyangiitis (MPA) Treatment Sales Market Share by Type (2015-2020)
Figure Global Microscopic Polyangiitis (MPA) Treatment Sales Market Share by Type in 2019
Table Global Microscopic Polyangiitis (MPA) Treatment Revenue by Type (2015-2020)
Table Global Microscopic Polyangiitis (MPA) Treatment Revenue Market Share by Type (2015-2020)
Figure Global Microscopic Polyangiitis (MPA) Treatment Revenue Market Share by Type in 2019
Figure Global Avacopan Sales Growth Rate (2015-2020)
Figure Global Avacopan Price (2015-2020)
Figure Global Immune Globulin Sales Growth Rate (2015-2020)
Figure Global Immune Globulin Price (2015-2020)
Figure Global Rituximab Biosimilar Sales Growth Rate (2015-2020)
Figure Global Rituximab Biosimilar Price (2015-2020)
Figure Global Others Sales Growth Rate (2015-2020)
Figure Global Others Price (2015-2020)
Table Global Microscopic Polyangiitis (MPA) Treatment Sales by Application (2015-2020)
Table Global Microscopic Polyangiitis (MPA) Treatment Sales Market Share by Application (2015-2020)
Figure Global Microscopic Polyangiitis (MPA) Treatment Sales Market Share by Application in 2019
Figure Global Hospital Sales Growth Rate (2015-2020)
Figure Global Clinic Sales Growth Rate (2015-2020)
Figure Global Others Sales Growth Rate (2015-2020)
Figure Global Microscopic Polyangiitis (MPA) Treatment Production (K Units) Growth Rate Forecast (2020-2025)
Figure Global Microscopic Polyangiitis (MPA) Treatment Revenue (Million US$) Growth Rate Forecast (2020-2025)
Figure Global Microscopic Polyangiitis (MPA) Treatment Price and Trend Forecast (2020-2025)
Table Global Microscopic Polyangiitis (MPA) Treatment Sales (K Units) Forecast by Region (2020-2025)
Figure Global Microscopic Polyangiitis (MPA) Treatment Production Market Share Forecast by Region (2020-2025)
Figure North America Microscopic Polyangiitis (MPA) Treatment Sales (K Units) Growth Rate Forecast (2020-2025)
Figure North America Microscopic Polyangiitis (MPA) Treatment Revenue (Million US$) Growth Rate Forecast (2020-2025)
Figure Europe Microscopic Polyangiitis (MPA) Treatment Sales (K Units) Growth Rate Forecast (2020-2025)
Figure Europe Microscopic Polyangiitis (MPA) Treatment Revenue (Million US$) Growth Rate Forecast (2020-2025)
Figure Japan Microscopic Polyangiitis (MPA) Treatment Production (K Units) Growth Rate Forecast (2020-2025)
Figure Japan Microscopic Polyangiitis (MPA) Treatment Revenue (Million US$) Growth Rate Forecast (2020-2025)
Figure China Microscopic Polyangiitis (MPA) Treatment Production (K Units) Growth Rate Forecast (2020-2025)
Figure China Microscopic Polyangiitis (MPA) Treatment Revenue (Million US$) Growth Rate Forecast (2020-2025)
Table Celltrion Inc Company Profile
Figure Microscopic Polyangiitis (MPA) Treatment Product Picture and Specifications of Celltrion Inc
Table Microscopic Polyangiitis (MPA) Treatment Production, Price, Revenue and Gross Margin of 2018-2020
Figure Celltrion Inc Microscopic Polyangiitis (MPA) Treatment Market Share (2018-2020)
Table Celltrion Inc Main Business
Table Celltrion Inc Recent Development
Table Teijin Pharma Ltd Company Profile
Figure Microscopic Polyangiitis (MPA) Treatment Product Picture and Specifications of Teijin Pharma Ltd
Table Microscopic Polyangiitis (MPA) Treatment Production, Price, Revenue and Gross Margin of 2018-2020
Figure Teijin Pharma Ltd Microscopic Polyangiitis (MPA) Treatment Market Share (2018-2020)
Table Teijin Pharma Ltd Main Business
Table Teijin Pharma Ltd Recent Development
Table ChemoCentryx Inc Company Profile
Figure Microscopic Polyangiitis (MPA) Treatment Product Picture and Specifications of ChemoCentryx Inc
Table Microscopic Polyangiitis (MPA) Treatment Production, Price, Revenue and Gross Margin of 2018-2020
Figure ChemoCentryx Inc Microscopic Polyangiitis (MPA) Treatment Market Share (2018-2020)
Table ChemoCentryx Inc Main Business
Table ChemoCentryx Inc Recent Development
Table Sandoz International GmbH Company Profile
Figure Microscopic Polyangiitis (MPA) Treatment Product Picture and Specifications of Sandoz International GmbH
Table Microscopic Polyangiitis (MPA) Treatment Production, Price, Revenue and Gross Margin of 2018-2020
Figure Sandoz International GmbH Microscopic Polyangiitis (MPA) Treatment Market Share (2018-2020)
Table Sandoz International GmbH Main Business
Table Sandoz International GmbH Recent Development
Table TTY Biopharm Company Ltd Company Profile
Figure Microscopic Polyangiitis (MPA) Treatment Product Picture and Specifications of TTY Biopharm Company Ltd
Table Microscopic Polyangiitis (MPA) Treatment Production, Price, Revenue and Gross Margin of 2018-2020
Figure TTY Biopharm Company Ltd Microscopic Polyangiitis (MPA) Treatment Market Share (2018-2020)
Table TTY Biopharm Company Ltd Main Business
Table TTY Biopharm Company Ltd Recent Development
Table of Appendix